Literature DB >> 22308460

Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms.

James M Amos-Landgraf1, Amy A Irving, Cory Hartman, Anthony Hunter, Brianna Laube, Xiaodi Chen, Linda Clipson, Michael A Newton, William F Dove.   

Abstract

Studies of tumors from human familial adenomatous polyposis, sporadic colon cancer, and mouse and rat models of intestinal cancer indicate that the majority of early adenomas develop through loss of normal function of the Adenomatous polyposis coli (APC) gene. In murine models of familial adenomatous polyposis, specifically the multiple intestinal neoplasia mouse (Min) and the polyposis in the rat colon (Pirc) rat, most adenomas have lost their WT copy of the Apc gene through loss of heterozygosity by homologous somatic recombination. We report that large colonic adenomas in the Pirc rat have no detectable copy number losses or gains in genomic material and that most tumors lose heterozygosity only on the short arm of chromosome 18. Examination of early mouse and rat tumors indicates that a substantial subset of tumors shows maintenance of heterozygosity of Apc in genomic DNA, apparently violating Knudson's two-hit hypothesis. Sequencing of the Apc gene in a sampling of rat tumors failed to find secondary mutations in the majority of tumors that maintained heterozygosity of Apc in genomic DNA. Using quantitative allele-specific assays of Apc cDNA, we discovered two neoplastic pathways. One class of tumors maintains heterozygosity of Apc(Min/+) or Apc(Pirc/+) RNA expression and may involve haploinsufficiency for Apc function. Another class of tumors exhibits highly biased monoallelic expression of the mutant Apc allele, providing evidence for a stochastic or random process of monoallelic epigenetic silencing of the tumor suppressor gene Apc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308460      PMCID: PMC3277532          DOI: 10.1073/pnas.1120753109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Polyclonal origin of colonic adenomas in an XO/XY patient with FAP.

Authors:  M R Novelli; J A Williamson; I P Tomlinson; G Elia; S V Hodgson; I C Talbot; W F Bodmer; N A Wright
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

2.  Characterization by electron microscopy of the complex formed between T4 bacteriophage gene 32-protein and DNA.

Authors:  H Delius; N J Mantell; B Alberts
Journal:  J Mol Biol       Date:  1972-06-28       Impact factor: 5.469

3.  Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice.

Authors:  W Edelmann; K Yang; M Kuraguchi; J Heyer; M Lia; B Kneitz; K Fan; A M Brown; M Lipkin; R Kucherlapati
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

4.  Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas.

Authors:  S A Hagstrom; T P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.

Authors:  A R Shoemaker; A R Moser; C A Midgley; L Clipson; M A Newton; W F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  De novo DNA methylation is dispensable for the initiation and propagation of X chromosome inactivation.

Authors:  Takashi Sado; Masaki Okano; En Li; Hiroyuki Sasaki
Journal:  Development       Date:  2004-03       Impact factor: 6.868

Review 7.  Genetic instabilities in human cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

Review 8.  Multiple mutations and cancer.

Authors:  Lawrence A Loeb; Keith R Loeb; Jon P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

9.  A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome.

Authors:  C J Brown; A Ballabio; J L Rupert; R G Lafreniere; M Grompe; R Tonlorenzi; H F Willard
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

10.  Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.

Authors:  Hengmi Cui; Marcia Cruz-Correa; Francis M Giardiello; David F Hutcheon; David R Kafonek; Sheri Brandenburg; Yiqian Wu; Xiaobing He; Neil R Powe; Andrew P Feinberg
Journal:  Science       Date:  2003-03-14       Impact factor: 47.728

View more
  9 in total

1.  The many ways to open the gate to colon cancer.

Authors:  James M Amos-Landgraf; Linda Clipson; Michael A Newton; William F Dove
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 2.  Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.

Authors:  Li Yang; P Charles Lin
Journal:  Semin Cancer Biol       Date:  2017-08-03       Impact factor: 15.707

Review 3.  How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.

Authors:  Shuji Ogino; Charles S Fuchs; Edward Giovannucci
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

4.  Homeostatic imbalance and colon cancer: the dynamic epigenetic interplay of inflammation, environmental toxins, and chemopreventive plant compounds.

Authors:  Melissa L Sokolosky; Michael J Wargovich
Journal:  Front Oncol       Date:  2012-06-01       Impact factor: 6.244

5.  Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture.

Authors:  Christopher D Zahm; Joseph M Szulczewski; Alyssa A Leystra; Terrah J Paul Olson; Linda Clipson; Dawn M Albrecht; Malisa Middlebrooks; Andrew T Thliveris; Kristina A Matkowskyj; Mary Kay Washington; Michael A Newton; Kevin W Eliceiri; Richard B Halberg
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

6.  Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.

Authors:  Cesar A Sommer; Amalia Capilla; Francisco J Molina-Estevez; Andreia Gianotti-Sommer; Nicholas Skvir; Ignacio Caballero; Sanjib Chowdhury; Gustavo Mostoslavsky
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

Review 7.  The utility of Apc-mutant rats in modeling human colon cancer.

Authors:  Amy A Irving; Kazuto Yoshimi; Marcia L Hart; Taybor Parker; Linda Clipson; Madeline R Ford; Takashi Kuramoto; William F Dove; James M Amos-Landgraf
Journal:  Dis Model Mech       Date:  2014-10-02       Impact factor: 5.758

Review 8.  Roles of tumor suppressors in regulating tumor-associated inflammation.

Authors:  L Yang; M Karin
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

9.  The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer.

Authors:  Jennifer K Pleiman; Amy A Irving; Zhishi Wang; Erik Toraason; Linda Clipson; William F Dove; Dustin A Deming; Michael A Newton
Journal:  PLoS Genet       Date:  2018-09-06       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.